Patent Owner's Notice of Appeal | Jan 2, 2019 | PAPER | PATENT OWNER |
Termination Decision Document | Oct 31, 2018 | PAPER | BOARD |
Updated Mandatory Notice | Aug 9, 2018 | PAPER | PETITIONER |
EXPUNGED | Aug 6, 2018 | PAPER | BOARD |
Hearing Transcript | Aug 6, 2018 | PAPER | BOARD |
Decision - Granting Unopposed Motion for Pro Hac Vice Admission of Mr. Ryan P. Johnson - 37 CFR 42.10(c) | Jul 16, 2018 | PAPER | BOARD |
Order - Trial Hearing - 37 CFR 42.70 | Jul 16, 2018 | PAPER | BOARD |
Pet. Motion for Pro Hac Vice of Ryan P. Johnson | Jul 12, 2018 | PAPER | PETITIONER |
Pet. Updated Exhibit List (as of 7-12-2018) | Jul 12, 2018 | PAPER | PETITIONER |
EX1040 Ryan Johnson Declaration | Jul 12, 2018 | EXHIBIT | PETITIONER |
Petitioner's Updated Mandatory Notice | Jul 10, 2018 | PAPER | PETITIONER |
Petitioner's Updated Power Of Attorney Appointing Additional Counsel | Jul 10, 2018 | PAPER | PETITIONER |
Petitioner's Reply To Opposition To Motion To Exclude Evidence | Jul 9, 2018 | PAPER | PETITIONER |
Patent Owner's Reply In Support of Motion to Exclude Evidence | Jul 9, 2018 | PAPER | PATENT OWNER |
Petitioner's Opposition To Patent Owner¿¿¿s Motion To Exclude Evidence | Jun 29, 2018 | PAPER | PETITIONER |
Petitioner's Response To Patent Owner's Motion For Observations | Jun 29, 2018 | PAPER | PETITIONER |
Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence | Jun 29, 2018 | PAPER | PATENT OWNER |
Petitioner's Motion To Exclude Evidence | Jun 22, 2018 | PAPER | PETITIONER |
Petitioner's Request For Oral Hearing | Jun 22, 2018 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List (As Of June 22, 2018) | Jun 22, 2018 | PAPER | PETITIONER |
Ex. 1039 - Freedman et al., "Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Dose Intensification with Granulocyte Colony-Stimulating Factor..." Blood, 90(12):4996-5001 (1997) | Jun 22, 2018 | EXHIBIT | PETITIONER |
Patent Owner's Motion for Observations on Cross Examination | Jun 22, 2018 | PAPER | PATENT OWNER |
Patent Owner's Motion to Exclude Evidence | Jun 22, 2018 | PAPER | PATENT OWNER |
Ex 2014 Lilford Publication | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Ex 2015 Freedman Publication | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Ex 2017 Soiffer Publication | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Ex 2018 Koreth Publication | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner's Request for Oral Argument | Jun 22, 2018 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jun 22, 2018 | PAPER | PATENT OWNER |
Ex 2013 Cook Publication | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Ex 2016 Petitioner's Reply to Patent Owner's Response (IPR2017-01168) | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Ex 2019 Fisher Publication | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Ex 2020 Soiffer Depo Transcript | Jun 22, 2018 | EXHIBIT | PATENT OWNER |
Petitioner's Objections To Exhibits | Jun 21, 2018 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notice | Jun 5, 2018 | PAPER | PETITIONER |
Granting Petitioner¿¿¿s Motion to Withdraw Counsel
37 C.F.R. sec. 42.5, 42.10(e) | Jun 4, 2018 | PAPER | BOARD |
Notice Of Joint Stipulation To Modify Due Dates 4-5 | Jun 1, 2018 | PAPER | PETITIONER |
Notice of Deposition of Robert J. Soiffer, M.D. | Jun 1, 2018 | PAPER | PATENT OWNER |
Petitioner's Unopposed Motion For Counsel To Withdraw | May 31, 2018 | PAPER | PETITIONER |
Patent Owner's Objections to Evidence | May 30, 2018 | PAPER | PATENT OWNER |
Petitioner's Reply To Patent Owner's Response | May 24, 2018 | PAPER | PETITIONER |
Ex. 1033 - McCoy et al., "A Novel Preparing Regimen for Autologous Transplant in Non-Hodgkin's Lymphomas: Long-Term Experience with Etoposide and Thiotepa," Bone Marrow Transplantation, 33:19-24 (2004) (as presented during Dr. Kahl deposition) ("Kahl") | May 24, 2018 | EXHIBIT | PETITIONER |
Ex. 1034 - Deposition Transcript of Brad S. Kahl, M.D., taken on April 14, 2018 | May 24, 2018 | EXHIBIT | PETITIONER |
Ex. 1035 - Declaration of Robert J. Soiffer, M.D. in support of Petitioner's Reply to Patent Owner's Response | May 24, 2018 | EXHIBIT | PETITIONER |
Ex. 1036 - Coiffier et al., "CHOP Chemotherapy Plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large B Cell Lymphoma," N.E. J. Med., 346:235-242 (2002) ("Coiffier 2022") | May 24, 2018 | EXHIBIT | PETITIONER |
Ex. 1038 - Freedman et al., "Autologous Bone Marrow Transplantation in Poor-Prognosis Intermediate-Grade and High-Grade B-cell non-Hodgkin's Lymphomas in First Remission: A Pilot Study," J. Clin. Oncol., 11(5):931-936 (1993) ("Freedman") | May 24, 2018 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List (As of May 24, 2018) | May 24, 2018 | PAPER | PETITIONER |
Ex. 1037 - Vose et al., "Phase II Study of Rituximab in Combination with CHOP Chemotherapy in Patients with Previously Untreated, Aggressive Non-Hodgkin¿¿¿s Lymphoma," J. Clin. Oncol., 19:389-397 (2001) ("Vose") | May 24, 2018 | EXHIBIT | PETITIONER |
Decision - Granting Unopposed Motion for Pro Hac Vice Admission of Mr. David Gindler - 37 CFR 42.10(c) | Apr 10, 2018 | PAPER | BOARD |
Notice Of Deposition Of Brad S. Kahl, M.D. | Mar 30, 2018 | PAPER | PETITIONER |
Petitioner¿¿¿s Objections To Exhibits | Mar 5, 2018 | PAPER | PETITIONER |
Ex 2002 IPR2017-01168 Petition | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2003 "What is a Stem Cell Transplant," Cancer.net, Jan. 2016 | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2004 Gribben, Effectiveness of High-Dose Combination Chemotherapy & Autologous Bone Marrow Transplantation | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2005 Philip, High-Dose Therapy and Autologous Bone Marrow Transplantation | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2007 Goss, Non-Hodgkin's Lymphomas in Elderly Patients | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2008 Ozer Depo Transcript | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2009 Kahl CV | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2010 Armitage, Treatment of Non-Hodgkin's Lymphoma | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2012 Song Declaration | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Feb 26, 2018 | PAPER | PATENT OWNER |
Ex 2006 Haioun, Benefit of Autologous Bone Marrow Transplantation | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Ex 2011 Kahl Declaration | Feb 26, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner Response | Feb 26, 2018 | PAPER | PATENT OWNER |
Joint Stipulation to Modify Due Date 1 | Feb 22, 2018 | PAPER | PATENT OWNER |
Motion to Appear Pro Hac Vice (Gindler) | Feb 14, 2018 | PAPER | PATENT OWNER |
Ex 2001 Gindler PHV Declaration | Feb 14, 2018 | EXHIBIT | PATENT OWNER |
Petitioner's Updated Mandatory Notice | Jan 31, 2018 | PAPER | PETITIONER |
Notice of Deposition of Howard Ozer | Jan 26, 2018 | PAPER | PATENT OWNER |
Granting Unopposed Motions for Pro Hac Vice Admissions | Jan 11, 2018 | PAPER | BOARD |
PETITIONER'S UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF ILAN WURMAN AND MATTHEW J. MEZGER | Jan 10, 2018 | PAPER | PETITIONER |
Ex. 1031 - Declaration of Ilan Wurman | Jan 10, 2018 | EXHIBIT | PETITIONER |
Ex. 1032 - Declaration of Matthew J. Mezger | Jan 10, 2018 | EXHIBIT | PETITIONER |
PETITIONER's UPDATED EXHIBIT LIST (AS OF JANUARY 10, 2018) | Jan 10, 2018 | PAPER | PETITIONER |
Patent Owner's Updated Mandatory Notice | Dec 27, 2017 | PAPER | PATENT OWNER |
Notice of Joint Stipulation to Modify Due Dates 1-2 | Dec 21, 2017 | PAPER | PATENT OWNER |
PETITIONER'S UPDATED POWER OF ATTORNEY | Dec 19, 2017 | PAPER | PETITIONER |
PETITIONER'S UPDATED MANDATORY NOTICE | Dec 19, 2017 | PAPER | PETITIONER |
PETITIONER'S SERVICE OF SUPPLEMENTAL EVIDENCE | Dec 5, 2017 | PAPER | PETITIONER |
Petitioner's Updated List of Exhibits (as of December 5 2017) | Dec 5, 2017 | PAPER | PETITIONER |
Petitioner's Unopposed Motion for PHV Admission of Charles B. Klein and Eimeric Reig-Plessis | Nov 20, 2017 | PAPER | PETITIONER |
Ex. 1025 - Declaration of Charles B. Klein ISO PHV Motion | Nov 20, 2017 | EXHIBIT | PETITIONER |
Ex. 1026 - Declaration of Eimeric Reig-Plessis ISO PHV Motion | Nov 20, 2017 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List (as of 11-20-2017) | Nov 20, 2017 | PAPER | PETITIONER |
Patent Owner's Objections to Exhibits | Nov 20, 2017 | PAPER | PATENT OWNER |
Scheduling Order | Nov 6, 2017 | PAPER | BOARD |
Trial Instituted Document | Nov 6, 2017 | PAPER | BOARD |
Power of Attorney | May 18, 2017 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notice | May 18, 2017 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | May 8, 2017 | PAPER | BOARD |
Petitioner's Power of Attorney | Apr 28, 2017 | PAPER | PETITIONER |
Ex. 1001 - White et al., U.S. Patent No. 8,821,873 B2 | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1003 - Caroline McNeil, "Non-Hodgkin's Lymphoma Trials In Elderly Look Beyond CHOP," J. Nat'l Cancer Inst., 90(4):266-67 (Feb. 18, 1998) ("McNeil") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1005 - Link et al., Phase II Pilot Study of the Safety and Efficacy of Rituximab , Thirty-Fourth Annual Meeting, (May 1998) ("Link") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1006 - Coiffier et al., "Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients with Relapsing or Refractory Aggressive Lymphoma: 92(6):1927-1932 (1998) ("Coiffier") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1008 - Maloney et al., "IDEC-C2B8: Results of a Phase I Multiple-Dose Trial in Patients with Relapsed Non-Hodgkin's Lymphoma," J. Clin. Oncol., 15(10):3266-3274 (1997) ("Maloney") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1009 - Shipp et al., "High-Dose CHOP as Initial Therapy for Patients with Poor-Prognosis Aggressive Non-Hodgkin's Lymphoma: A Dose-Finding Pilot Study," J. Clin. Oncol., 13(12):2916-2923 (1995) ("Shipp") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1011 - W. Hiddemann, "Non-Hodgkin's Lymphoma - Current Status of Therapy and Future Perspectives," Eur. J. Cancer, 31A:2141-2145 (1995) ("Hiddemann II") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1013 - Kenneth A. Foon & Richard I. Fisher, "Lymphomas," Hematology, 5th Ed. (1995), 1076-1096 ("Foon") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1015 - Arthur T. Skarin & David M. Dorfman, "Non-Hodgkin's Lymphomas: Current Classification and Management," CA Cancer J. Clinicians, 47(6):351-372 (1997) ("Skarin") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 2 | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 3 | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 4 | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1004 - Rituxan (rituximab) labeling (Nov. 1997) ("Rituxan label") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1007 - Moreau et al., "Peripheral Blood Stem Cell Transplantation as Front-line Therapy in Patients Aged 61 to 65 Years: A Pilot Study," Bone Marrow Transplantation, 21:1193-1196 (1998) ("Moreau") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1010 - Martelli et al., "Current Guidelines for the Management of Aggressive Non-Hodgkin's Lymphoma," Drugs, 53(6):957-972 (1997) ("Martelli") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1012 - Hiddemann et al. "Lymphoma Classification - The Gap Between Biology and Clinical Management is Closing," Blood, 88(11):4085-4089 (1996) ("Hiddemann III") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1014 - Michael J. Campbell & John E. Niederhuber, "B-Lymphocyte Responses," Clinical Oncology, Abeloff et al., Eds. (1995), 100-126 ("Campbell") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 1 | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 5 | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1017 - Michael L. Grossbard et al., "Monoclonal Antibody-Based Therapies of Leukemia and Lymphoma," Blood, 80(4):863-878 (1992) ("Grossbard") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1020 - U.S. Application No. 14/045,375, Amendment and Response to Non-Final Office Action (dated Feb. 14, 2014) | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1021 - U.S. Application No. 14/045,375, Notice of Allowability (dated Mar. 25, 2014) | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1018 - James O. Armitage et al., "Bone Marrow Transplantation," Clinical Oncology, Abeloff et al., Eds. (1995), 295-305 ("Armitage I") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1019 - U.S. Application No. 14/045,375, Non-Final Office Action (dated Jan. 6, 2014) | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1022 - Tsai et al., "Progressive Intermediate Grade Non-Hodgkin's Lymphoma After High Dose Therapy," Blood, 92(10 Suppl. 1):415a (1998) ("Tsai") | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1023 - Physicians' Desk Reference (53rd ed. 1999) (excerpted), "Rituxan
(Rituximab)" | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1024 - U.S. Application No. 14/045,375, Utility Patent Application Transmittal (dated Oct. 3, 2013) | Apr 28, 2017 | EXHIBIT | PETITIONER |
Ex. 1002 - Declaration of Ozer, M.D., Ph.D. | Apr 28, 2017 | EXHIBIT | PETITIONER |
PETITION FOR INTER PARTES REVIEW | Apr 28, 2017 | PAPER | PETITIONER |